Monitoring Response to Transarterial Chemoembolization in Hepatocellular Carcinoma Using (18)F-Fluorothymidine PET

Accurate disease monitoring is essential after transarterial chemoembolization (TACE) in hepatocellular carcinoma (HCC) because of the potential for profound adverse events and large variations in survival outcome. Posttreatment changes on conventional imaging can confound determination of residual...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Rohini, Inglese, Marianna, Dubash, Suraiya, Lu, Haonan, Pinato, David J., Sanghera, Chandan, Patel, Neva, Chung, Anthony, Tait, Paul D., Mauri, Francesco, Crum, William R., Barwick, Tara D., Aboagye, Eric O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society of Nuclear Medicine 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8679631/
https://www.ncbi.nlm.nih.gov/pubmed/32513905
http://dx.doi.org/10.2967/jnumed.119.240598

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8679631/
https://www.ncbi.nlm.nih.gov/pubmed/32513905
http://dx.doi.org/10.2967/jnumed.119.240598

Ejemplares similares